Travelzoo
Travelzoo (TZOO) Financial Performance & Income Statement Overview
Review Travelzoo (TZOO) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Travelzoo (TZOO) Income Statement & Financial Overview
Analyze Travelzoo’s TZOO earnings with segmented quarterly and yearly financial statement figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $23.14M | $20.68M | $20.10M | $21.14M |
Cost of Revenue | $4.17M | $2.76M | $2.55M | $2.52M |
Gross Profit | $18.97M | $17.92M | $17.55M | $18.62M |
Gross Profit Ratio | $0.82 | $0.87 | $0.87 | $0.88 |
R&D Expenses | $634000.00 | $644000.00 | $594000.00 | $603000.00 |
SG&A Expenses | $14.53M | $12.42M | $12.91M | $14.007M |
Operating Expenses | $15.16M | $13.07M | $13.51M | $14.61M |
Total Costs & Expenses | $19.34M | $15.83M | $16.05M | $17.13M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $76000.00 | $170000.00 | $179000.00 | $175000.00 |
EBITDA | $3.88M | $4.92M | $4.04M | $4.19M |
EBITDA Ratio | $0.17 | $0.24 | $0.20 | $0.20 |
Operating Income | $3.80M | $4.85M | $4.04M | $4.01M |
Operating Income Ratio | $0.16 | $0.23 | $0.20 | $0.19 |
Other Income/Expenses (Net) | $418000.00 | -$86000.00 | $359000.00 | $176000.00 |
Income Before Tax | $4.16M | $4.76M | $4.40M | $4.19M |
Income Before Tax Ratio | $0.18 | $0.23 | $0.22 | $0.20 |
Income Tax Expense | $1.13M | $1.48M | $1.15M | $1.27M |
Net Income | $3.03M | $3.22M | $3.18M | $2.93M |
Net Income Ratio | $0.13 | $0.16 | $0.16 | $0.14 |
EPS | $0.26 | $0.27 | $0.26 | $0.23 |
Diluted EPS | $0.25 | $0.26 | $0.26 | $0.23 |
Weighted Avg Shares Outstanding | $11.67M | $11.83M | $12.18M | $12.89M |
Weighted Avg Shares Outstanding (Diluted) | $12.25M | $12.36M | $12.39M | $12.98M |
Financial performance has remained strong, with revenue growing from $21.14M in Q2 2024 to $23.14M in Q1 2025. Gross profit continued to perform well, with margins at 82% in the latest quarter. Operating income reached $3.80M in Q1 2025, holding a steady 16% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $3.88M. Net income dropped to $3.03M, keeping EPS at $0.26. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan